Results 251 to 260 of about 849,713 (290)

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease

open access: yesMolecular Oncology, EarlyView.
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park   +6 more
wiley   +1 more source

Validation and reliability of the Italian versions of the Food Allergy Quality of Life -Parental Burden (FAQL-PB) and -Parent Form 10 (FAQLQ-PF10) Questionnaires. [PDF]

open access: yesPediatr Allergy Immunol
Comberiati P   +11 more
europepmc   +1 more source

Environmental Toxic Elements and Atherosclerotic Disease: The Epigenetic Connection. [PDF]

open access: yesLife (Basel)
Simonini L   +4 more
europepmc   +1 more source

Narrowband Emitting Tin Dion-Jacobson Perovskites through Systematic Spacer Cation Design to Suppress Metal Lone-Pair Anisotropy. [PDF]

open access: yesJ Am Chem Soc
Forlano KM   +12 more
europepmc   +1 more source

Systematic versus perilesional sampling in transperineal MRI-fusion biopsy: is perilesional sampling ready for prime time? A high-volume center analysis. [PDF]

open access: yesWorld J Surg Oncol
Seebold A   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy